Doxazosin
NDC 71610-482, Doxazosin Mesylate, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-482
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-482 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-482-60 | 71610048260 | 90 TABLET in 1 BOTTLE (71610-482-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6b74b18f-b89a-4109-a29e-c4fa65a3c5ee
Use it
Look up 71610-482 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-482 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-482. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.